San Diego, CA -- (SBWIRE) -- 06/09/2015 -- An investigation on behalf of current long-term investors in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shares was announced over potential breaches of fiduciary duties by certain officers and directors at Vertex Pharmaceuticals.

Investors who purchased shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) and currently hold any of those NASDAQ:VRTX shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Vertex Pharmaceuticals officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.

On May 26, 2015, it was reported that two leading advisory firms are recommending that shareholders vote against executive pay packages at Vertex Pharmaceuticals Inc., calling aspects of last year's compensation at Vertex Pharmaceuticals Incorporated "excessive" and "exorbitant."

On June 5, 2015, NASDAQ:VRTX shares closed at $127.35 per share.

Those who purchased shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com